UP experts discuss the COVID-19 pandemic

As South Africa responds to the local spread of a global pandemic, University of Pretoria (UP) researchers are at the forefront of research into zoonotic diseases – which can be transmitted from animals to humans – via collaborative research between our Faculties of Health Sciences, Natural and Agricultural Sciences, and Veterinary Science.

As COVID-19 spreads, the work of UP’s Centre for Viral Zoonoses (UP CVZ) has also become even more vital. The UP CVZ is a Centre of Excellence for research into viral zoonotic diseases, and pulls together research strengths in arbovirology, bat and other small mammal viral zoonotic diseases, rabies and rabies-related lyssaviruses, viral pathology, medical entomology and ecology, to uncover how these viruses transmit, inhabit, and what contains or cures them.

Watch the video in the sidebar to view the discussion amongst some of the University of Pretoria’s leading experts from these Faculties and the UP CVZ  who explain COVID-19 and what it means for South Africa as the global pandemic begins to spread.

The expert lineup includes:

  • Professor Anton Stoltz (Head of the Division of Infectious Diseases in the Department of Internal Medicine);
  • Professor Wanda Markotter (NRF-DSI South African Research Chair in Animal Infectious Diseases and Director of the Centre for Viral Zoonoses); and,
  • Professor Marietjie Venter (Head of the Zoonotic Arbo- and Respiratory Virus Research Programme at the Centre for Viral Zoonosis).

Professors Anton Stoltz, Marietjie Venter, Wanda Markotter

March 17, 2020

  • Estimated Reading Time: 1 minute

Researchers
  • Professor Wanda Markotter
    Professor Wanda Markotter is a virologist who began her academic career at the University of Pretoria (UP) in 2004 and is currently the Director of its Centre for Viral Zoonoses in the Department of Medical Virology at the University’s Faculty of Health Sciences.

    In January 2016, the DSI-NRF South African Research Chairs (SARChI) Initiative awarded her the Chair in Animal Infectious Diseases (Zoonoses). Prof Markotter has been involved in a transdisciplinary research programme on disease ecology in bat species in South Africa and other African countries since 2005. Her research includes extensive fieldwork that focuses on bats and potential spillover hosts, virological testing, bat biology, ecological investigations and human behaviour studies. The focus is not only to detect viruses but to understand the factors involved in spillover and to develop mitigation strategies. More than 40 postgraduate students have graduated under her supervision, and she has mentored several postdoctoral fellows and emerging researchers.

    Prof Markotter has published more than 70 scientific publications and several book chapters, and regularly contributes to public media forums. Her research is supported by several multi-collaborative international viral surveillance programmes and institutions, including the Global Disease Detection Programme, the Centres for Disease Control and Prevention, and the Defence and Threat Reduction Agency in the USA. She also plays a leading role in several governmental committees, including the National Rabies Advisory Group and the National One Health Forum.

    What got you interested in virology?

    Viruses are not considered alive, and are so small, you cannot see them with the naked eye or even with a normal light microscope. You need a special electron microscope. However, they’re responsible for the world deadliest diseases. It has always fascinated me that an organism so small can infect you without you even knowing it happened. It then uses the infected host’s machinery to amplify and cause damage. To understand their mechanisms of action and how to prevent and treat infections is something I want to understand.

    What’s the most fascinating thing you’ve learnt about bats?

    Bats have adapted to carry deadly viruses without these viruses causing any harm to the animal itself. The “flight as fever” hypothesis states that bats have developed unique mitochondrial and DNA repair pathways – flight leads to higher metabolic rates and higher body temperatures, which the adaptations help the animal to deal with. The same adaptations also assist in controlling viral replication. The higher body temperature simulates a fever that also assists in viral control. Other hosts, like humans, can’t control these viruses when they spillover. However, there isn’t good experimental evidence yet for this theory. More studies on the immune system of bats are now being done, but there is no conclusive evidence on whether they have a unique immune system that assists in controlling these viruses.

    What do think COVID-19 has taught the world?

    We should never be complacent; emerging novel diseases can be introduced into the human population at any time. There are many reasons for this, but most of them have to do with the pressures on the environment. We are causing these introductions by our actions, and I think COVID-19 has taught us to really think about how we should responsibly interact with our environment and animals. We need to prevent spillover. There will be another disease and another opportunity for spillover. To react only when it is already a disease transmitted between humans is too late and extremely costly, both in human lives and economic impact. It requires a holistic approach among scientists, communities, governments and NGOs focused on developing mitigation strategies that are practical for high-risk communities to prevent spillover.

    Many people believe that COVID-19 might be around for quite some time. What does the research around coronaviruses show us?

    Time will tell. COVID-19 is a mild disease among a high majority of people, making it difficult to identify infections. This was different for MERS and SARS, which caused severe disease; infected people were then isolated and the spread prevented. This has led to the theory that COVID-19 could become seasonal, like influenza. Several factors might play a role in this, including how long infected people stay immune. If there is only short immunity, in the absence of a vaccine, it’s more likely that we will see annual outbreaks. It will also depend on the degree to which the weather affects the virus; this will become clearer as some countries approach a different season.

    Was the global spread of COVID-19 something that you anticipated would happen in our lifetime?

    If we look at the history of emerging diseases, it’s something that could have been expected. However, I do not think we anticipated the “when”, “how” and the impact of COVID-19. Previous outbreaks like SARS did not have the global impact that COVID-19 has had, as those outbreaks were more geographically restricted. I never imagined that we would experience a pandemic that involved lockdown for extended periods and us wearing masks for months.

    If people have bats on their property, is it something to be concerned about? At what point do bats become pests and how does one safely remove them?

    Bats are a very important part of our ecological system and are all around us. Frugivorous bats play a role in seed dispersal and pollination of flowers. Insectivorous bats eat insects including mosquitoes. Removing bats will cause an imbalance in the ecosystem, which will cause other problems. However, it does become a problem if there is contact with their excretions, such as urine and faecal matter. This is typically a problem when they move into the roofs of buildings and populations increase. Bats are protected and you are not allowed to exterminate them. Safe removal will depend on the situation; the best thing to do is to contact a bat interest group for advice (http://batsgauteng.org.za). Also, do not handle bats without the necessary protections, to avoid bites or scratches or any contact with bodily fluids.

    How well placed is South Africa to lead research initiatives into coronaviruses like Ebola, SARS, COVID-19 and MERS?

    We are well placed to do this sort of research. Historically speaking, South African scientists were leading Ebola and Marburg virus research; this has expanded to include other potential zoonotic viruses, including coronaviruses. Knowing the diversity of pathogens in bats, and when and where they can be transmitted is important. Routes of transmission must be clearly understood; it can be different depending on the virus or it could be seasonal. This is the basic information needed to start with, but this alone will not stop outbreaks. We need to understand contact with people and other animals, and the risk of transmission. This cannot be extrapolated globally and could be geographic specific due to cultural practices and social needs. Being on the African continent with significant expertise and infrastructure enables South African researchers to play a leading role and perform long-term studies that can provide answers on reasons for spillover. We need to go beyond just testing bats for viruses.

    We have the expertise to take a transdisciplinary approach. Studying these viruses also requires high biocontainment facilities – UP has biosafety level 3 facilities, and through our collaboration with the National Institute for Communicable Diseases, we also have biosafety level 4 capabilities, the only one in Africa. South Africa is therefore playing a leading role in the African region.

    If you are a researcher who would like to work with UP’s CVZ, email Prof Markotter at [email protected].
    More from this Researcher
  • Professor Marietjie Venter
    Professor Marietjie Venter joined the University of Pretoria (UP) in 2006 and established a research programme on neurological arboviruses and respiratory viruses, in the Department Medical Virology.
    In 2009, she became Co-director of the Centre for Respiratory Diseases and Meningitis at the National Institute for Communicable Diseases (NICD) of South Africa. She then worked for two years for the US Centers for Disease Control and Prevention, and the Global Disease Detection Centre in South Africa as One Health and Emerging Disease Programme Director. Prof Venter maintained a part-time joint appointment with UP to continue her research programme and supervised postgraduate students between 2009 and 2016, first as an associate professor and later as a full professor. In 2016 she took up a full-time position as a full professor in medical virology and as Head of the Zoonotic Arbo- and Respiratory Virus Programme (ZARV).
    Prof Venter holds a BSc in Molecular Biology, Genetics and Microbiology from UP and a PhD in Medical Virology from the University of the Witwatersrand (2003) with a focus on the respiratory syncytial virus (RSV). She also received postdoctoral training on the West Nile virus at the National Institute for Allergy and Infectious Diseases in the US (2003).
    Prof Venter established a One Health programme in the Department of Medical Virology that focuses on detecting and describing emerging and zoonotic vector-borne and respiratory viruses. There is close collaboration between the ZARV medical virology group in the medical school, veterinarians, veterinary pathologists and clinicians as well as entomologists. This collaboration has been extremely productive in describing the molecular epidemiology of vector-borne and respiratory viruses.
    The Department of Medical Virology has a state-of-the-art biosafety level 3 laboratory, which was funded and commissioned in 2011, and which has been the core infrastructure for Prof Venter’s research programme. She co-founded the steering committee of the Centre for Viral Zoonoses, which was launched around this infrastructure in 2015 and stretches across three faculties.
    In terms of far-reaching impact, Prof Venter says her research programme focuses on developing diagnostic tools and syndromic surveillance programmes for detecting novel and common pathogens, discovering new viruses, and defining the importance of zoonotic and human viruses with epidemic and pandemic potential. Vector-borne viruses associated with neurological symptoms – such as the West Nile and Zika viruses as well as respiratory viruses such as influenza A and coronaviruses – have been some of the most important emerging epidemic- and pandemic-prone viruses. “Our capacity to detect and respond to emerging diseases using a One Health approach and defining the clinical epidemiology and genomics has been very topical during the COVID 19 pandemic,” she says.
    Since 2020, Prof Venter has been part of several COVID-19 investigations, specifically the genomic surveillance network with the University of KwaZulu-Natal as well as the National Health Laboratory Service, NICD, the Universities of Cape Town and the Free State. Apart from working closely with UP’s Faculty of Veterinary Science, her research programme also works with clinicians in Kalafong and Steve Biko hospitals to detect acute febrile disease of unknown origin, respiratory viruses and zoonotic infections.
    Prof Venter holds the position of vice-president for Africa for the World Society of Virology and is a member of the international One Health Platform Scientific Advisory Board. She is the principal investigator for a study on febrile disease of unknown origin with or without neurological signs for the African network for improved diagnostics and epidemiology of common and emerging viruses. In addition, she is the principal investigator for South Africa on the Long-term Europe-African Research Network (LEARN) study of the LEAP-Agri Initiative, which is funded by the EU and administered by the National Research Foundation. It is a One Health initiative for the development of molecular and serological tools for the surveillance of arboviruses in animals and human, and is being conducted in collaboration with Wageningen University in the Netherlands and the Friedrich-Loeffler Institut in Greifswald, Germany.
    Over the past year, Prof Venter’s programme took up the ANDEMIA respiratory virus work package at UP in collaboration with the NICD and the Robert Koch Institute in Germany. The ANDEMIA network study has allowed the researchers to carry out active surveillance and define the correlates of disease for both zoonotic and common pathogens. “We obtained additional funding through the G7 as part of the ANDEMIA grant to investigate COVID-19 genomics, seroprevalence and infection risk in healthcare workers as well as co-infections. We are also investigating reverse zoonotic transmission from humans to wildlife.”
    Dutch virologist Dr Ab Osterhaus, founder of the One Health Platform, inspires Prof Venter’s research efforts. He and his team described several viruses including the original SARS coronavirus. He also actively involves many young scientists such as Prof Venter in international networks to promote One Health aimed at detecting and preventing potential zoonotic disease outbreaks and pandemics. Prof Venter says she has also been inspired by several African scientists who have dedicated their lives to fighting infectious diseases in their home countries.
    The professor says that she has had several role models and mentors throughout her career, but that Prof Barry Schoub, former director of the NICD, stands out for her. He dedicated his career to fighting infectious diseases through research, by supporting his staff and by advising policy nationally and globally. Prof Schoub was both Prof Venter’s PhD mentor and supervisor at the NICD and has maintained an interest in her career.
    She has always been motivated to improve the lives of humans and animals by investigating the viral causes of respiratory and neurological infections through virus discovery, molecular epidemiology, pathogenesis research and the development of diagnostic tools and preventative strategies such as vaccines.
    “I have been involved in vaccine research over the years, and have found it to be very rewarding,” she says. “For instance, the West Nile virus vaccine was licensed for horses after we proved that it protects against lineage two variants that are dominant in South Africa.” She says she would like to focus some of her work in this area again, trying to find vaccines for viruses that have the potential to cause epidemics and spread internationally.
    Prof Venter says her research matters because it focuses on improving the ability to detect, respond and control important viruses such as RSV, influenza, COVID-19, the West Nile virus and emerging arboviruses, thereby contributing to the international health regulations for countries to respond to zoonotic viruses and the United Nations Sustainable Development Goals 3: Good health and well-being.
    For school learners or undergraduates who are interested in her field of study, Prof Venter says that a career in virology offers opportunities to work in the field of public health or as a laboratory scientist internationally or locally. She adds that virologists get to investigate unsolved diseases, discover new viruses and develop technologies that can save lives and improve health for humans and animals.
    In her spare time, Prof Venter is a competitive dressage rider, a member of the South African Warmblood Society and a breeder of warmblood horses.


    More from this Researcher
  • Professor Anton Carel Stoltz (In Memoriam)
    Professor Anton Carel Stoltz was one of South Africa's top infectious disease experts. He started his career as a biochemist and researcher. In 1983 he completed his honours degree in biochemistry with research into the physical properties of IgM molecules. His master’s degree in biochemistry focused on malaria. He then went on to study medicine and while doing his MMed (Internal Medicine) he was selected to go to Belgium as a researcher to pioneer a new field in tuberculosis (TB), working in the world-class laboratories of Professor Johan Grooten at Ghent University and Patric De Baetselier at the University of Brussels. The function of mycolic acids in the cell wall of mycobacterium TB was at that stage unknown. He was asked to start a new field in lipid biochemistry and look at immunological properties of these long chain fatty acids. After two years, he published a paper on the innate immunity of mycolic acids. Papers that followed were on the use of biosensors to detect anti-mycolic acid antibodies and its use in a novel assay for tuberculosis.

    This was the start of a career in which he dedicated himself unconditionally and with single-minded dedication to relieving the burden of infectious diseases. In 2010 he became the head of the Division of Infectious Diseases at UP, after Health Professions Council of South Africa-registration as a subspecialist in infectious diseases. He was an internist and infectious diseases subspecialist with interests in the management of patients with multi-drug resistant and extensive drug-resistant TB co-infected with HIV; and diseases originating from Africa, including severe malaria, schistosomiasis and drug resistant infections in intensive-care units. His research interests were in the field of infectious diseases, including resistant tuberculosis using novel nano-particle medicine, resistant tuberculosis transmission/aerobiology and novel prevention of infection, HIV infections and the heart plus HIV and CMV co-infections, malaria pheromones and malaria drug reformulations.

    He was the ultimate overachiever – he worked with various intensive-care units at the referral academic hospital; initiated an Infection Prevention and Control unit as well as antibiotic stewardship from several Centers for Disease Control grants. These projects were used as a platform to teach healthcare workers, students and hospital managers the correct management of infectious diseases and infection control practices. He was also a consultant to the Council for Scientific and Industrial Research (CSIR) and to UP’s TB research programmes, focusing on nano-particle medicine and novel diagnostics in TB. He was involved in a major breakthrough in collaborative research with the University of Leicester in revolutionising the way TB is detected, through the invention and application of a 3D-printed insert added to simple face masks. This new approach has the potential to detect millions of currently missed infections across the world.

    Since February 2020 he had dedicated his time to the fight against the COVID-19 pandemic, despite facing personal setbacks in his own health. He yet again proved his dedication to bettering the lives of others, and will forever be remembered for his clinical excellence, his dedication to research, his unfaltering leadership and his unwavering love for his children and wife.

    We mourn the loss of this talented hero, who devoted his life to saving the lives of others.
    More from this Researcher

Related Video

Other Related Research

Copyright © University of Pretoria 2024. All rights reserved.

Share